Generic Aldara ( Imiquimod )

Order cheap Generic Aldara (Imiquimod) without dr prescription in the United States

At our pharmacy, you can purchase Aldara without a prescription, with delivery throughout the USA within 5-14 days. Discreet and anonymous packaging.
Aldara is used for the topical treatment of actinic keratosis (precancerous skin lesions), superficial basal cell carcinoma, and external genital/perianal warts caused by human papillomavirus (HPV). The medication is an immune response modifier that stimulates the body's own immune system to produce cytokines (interferon‑α, tumor necrosis factor‑α) and activate immune cells, leading to the clearance of abnormal skin growths and warts.
The usual dosage of Aldara is applied 2‑5 times per week (depending on the condition) as a thin layer to the affected area before bedtime, left on the skin for 6‑10 hours, then washed off with mild soap and water.
The administration form is a topical cream (5% imiquimod) in single‑use sachets or a pump dispenser.
The effect of the medication begins within several weeks, with complete clearance typically seen after 4‑16 weeks of regular use.
The duration of action varies; treatment courses range from 4 weeks (genital warts) up to 16 weeks (actinic keratosis and basal cell carcinoma).
Alcohol consumption is not directly contraindicated, but it is advisable to avoid excessive alcohol during any medical treatment.
The most common side effects are local skin reactions such as redness, swelling, itching, burning, and erosion at the application site.
Would you like to try Aldara without a prescription?

Basic Aldara Information

• INN (International Nonproprietary Name): Imiquimod
• Brand names available in USA: Aldara®, Zyclara®
• ATC Code: D06BB10
• Forms and dosages: Topical cream – 5% (in single‑use 250 mg sachets or pump dispenser); also available as 2.5% and 3.75% for Zyclara
• Manufacturers in USA: Graceway Pharmaceuticals (now Bausch Health), Medicis (now Valeant)
• Registration status in USA: Approved by FDA
• OTC / Rx classification: Prescription only (Rx)

Mechanism and Pharmacology

Imiquimod is a toll‑like receptor 7 (TLR7) agonist. When applied topically, it activates TLR7 on dendritic cells, macrophages, and monocytes, leading to the production and release of pro‑inflammatory cytokines such as interferon‑α, interleukin‑6, and tumor necrosis factor‑α. These cytokines stimulate a cell‑mediated immune response that recruits immune cells (T‑cells, natural killer cells) to the application site, resulting in the destruction of abnormal keratinocytes (actinic keratosis, basal cell carcinoma) or HPV‑infected cells (genital warts). Imiquimod has no direct antiviral or antiproliferative activity; its effect is entirely immune‑mediated.

Indications and Usage

Aldara is indicated for the topical treatment of:
- External genital and perianal warts (condylomata acuminata) in adults aged 18 years and older.
- Actinic keratosis on the face or scalp in immunocompetent adults.
- Superficial basal cell carcinoma (sBCC) in adults when surgical removal is medically less appropriate.
It is also used off‑label for other cutaneous conditions (e.g., molluscum contagiosum, cutaneous leishmaniasis) but efficacy is not well established.

Critical Warnings and Limitations

High‑Risk Groups
Elderly: No dose adjustment necessary; elderly patients may be more susceptible to local skin reactions.
Pregnancy: FDA Pregnancy Category C. Use only if potential benefit justifies potential risk to the fetus. Systemic absorption is minimal but not zero.
Breastfeeding: Unknown whether imiquimod is excreted in human milk. Caution advised; apply on areas away from the breast if possible.

Activity Interactions
Driving: Not applicable; topical use does not affect mental alertness.
Alcohol: No known interaction, but alcohol may worsen skin irritation if consumed excessively.

Dosage Guide

Standard Regimens
External genital/perianal warts: Apply 5% cream 3 times per week (e.g., Monday, Wednesday, Friday) before bedtime. Wash off after 6‑10 hours. Continue until warts are cleared, up to 16 weeks. Do not exceed 16 weeks of treatment.
Actinic keratosis: Apply 5% cream 2 times per week (e.g., Monday and Thursday) before bedtime. Wash off after 8 hours. Treat for 16 weeks. The 3.75% formulation (Zyclara) is applied once daily for 2 weeks on, 2 weeks off, repeated once.
Superficial basal cell carcinoma: Apply 5% cream 5 times per week (once daily, 5 consecutive days) before bedtime. Wash off after 8 hours. Treat for 6 weeks.

Special Populations
Renal or hepatic impairment: No dose adjustment needed; systemic absorption is negligible.
Pediatric: Safety and efficacy in children under 12 years (for genital warts) or under 18 years (for actinic keratosis/sBCC) have not been established.

Side Effects and Contraindications

Common side effects (local skin reactions):
- Erythema (redness)
- Edema (swelling)
- Induration (hardening)
- Erosion, ulceration, or crusting
- Pruritus (itching)
- Burning sensation
- Pain at application site

Serious side effects requiring medical attention:
- Severe local reactions (blistering, ulceration, necrosis)
- Flu‑like symptoms (fatigue, fever, myalgia) – rare
- Systemic hypersensitivity (angioedema, urticaria)
- Hyper‑ or hypopigmentation at the treatment site (usually reversible)

Absolute contraindications:
- Hypersensitivity to imiquimod or any excipient in the cream.
- Do not use on open wounds, on mucous membranes (eyes, mouth, nose, vagina), or on areas of severe inflammation.

Drug Interactions

Topical imiquimod has minimal systemic absorption, so clinically significant drug interactions are unlikely. However, avoid applying other topical medications (including corticosteroids, retinoids, or other irritants) to the same area unless directed by a physician. There are no known interactions with oral medications due to low systemic exposure.

Practical Guidelines

Administration
Wash the treatment area with mild soap and water and pat dry before application. Apply a thin layer of cream to the lesion(s) and rub in gently. Wash hands immediately after application. Do not use occlusive dressings. Leave the cream on for 6‑10 hours (8 hours for actinic keratosis and sBCC). After the required time, wash off the cream with mild soap and water. Avoid bathing or swimming during the application period.

Monitoring
Regular follow‑up with a healthcare provider is essential to assess treatment response and monitor for adverse effects. For actinic keratosis and sBCC, a follow‑up skin examination is recommended at 4‑8 weeks after completing treatment. For genital warts, patients should be examined every 4‑6 weeks.

Storage
Store at room temperature (20‑25°C / 68‑77°F), away from moisture and heat. Do not freeze. Keep sachets in the outer carton until use. Single‑use sachets are for one application only; discard any unused cream.

Alternative Medications

• Fluorouracil (5‑FU) topical cream: Antimetabolite for actinic keratosis and superficial basal cell carcinoma; causes intense inflammation.
• Ingenol mebutate (Picato): For actinic keratosis; shorter treatment (2‑3 days) but discontinued in some markets due to safety concerns.
• Dicloferac sodium (Solaraze) gel: NSAID for actinic keratosis; slower acting.
• Cryotherapy (liquid nitrogen): Destructive treatment for actinic keratosis and warts.
• Podophyllin resin or podofilox (Condylox): For genital warts; antimitotic agent.
• Sinecatechins (Veregen) ointment: Green tea extract for genital warts.
• Surgical excision or curettage: For superficial basal cell carcinoma.

Clinical Effectiveness

In clinical trials, imiquimod 5% cream achieved complete clearance of actinic keratosis in 45‑57% of patients after 16 weeks of treatment (2 applications per week). For superficial basal cell carcinoma, histologic clearance rates were 75‑82% after 6 weeks of daily application. For external genital/perianal warts, complete clearance was observed in 50‑70% of patients after up to 16 weeks of treatment (3 applications per week). Recurrence rates for warts are approximately 10‑20% within 6 months. Imiquimod is less effective for keratinized warts (e.g., common warts) and is not indicated for those.

Important: Aldara requires medical supervision and should only be used under prescription. Do not use on areas other than those specified by your doctor. Avoid sexual contact when the cream is on the skin, as it may weaken condoms and irritate partners. If severe local reactions (e.g., blistering, ulceration) occur, interrupt treatment and consult your healthcare provider. Regular skin checks are essential, especially for actinic keratosis and basal cell carcinoma, to monitor for new lesions or incomplete response.

How to buy Generic Aldara no prescription U.S. Online Pharmacy